NewGen closes K25.ai Pre-A round, market cap hits US$7.6 million
NewGenIVF Group Limited completed a US$10 million Pre-A investment in K25.ai, securing a 10% stake and exclusive Asia-Pacific agency rights. The company's market capitalization reached US$7,631,710 on June 18, 2026, with total outstanding shares at 10,073,535. NewGen views its market cap as a discount to its net asset value of US$25.98 million as of December 31, 2025.

*this image is generated using AI for illustrative purposes only.
NewGenIVF Group Limited has executed an agreement for a further US$4 million strategic investment in K25.ai, completing the target company's US$10 million Pre-A round at a US$100 million valuation. This transaction increases NewGen's aggregate ownership interest in K25.ai to 10%, subject to the satisfaction of applicable closing conditions. The expanded stake includes exclusive Asia-Pacific agency rights, deepening NewGen's strategic participation in K25.ai's next phase of growth. Following the share issuances related to this acquisition, NewGen's total outstanding shares now stand at 10,073,535, and its market capitalization reached US$7,631,710 on June 18, 2026.
Management views this market capitalization as representing a substantial discount to the Company’s net asset value of approximately US$25.98 million as of December 31, 2025. The balance sheet has been further strengthened by the Company’s subsequent US$10 million investment in K25.ai. This capital strength follows the Company’s recently announced strategic direction shift, including the definitive investment agreement with K25.ai, an AI-powered live-streaming prediction market platform, and the adoption of a digital assets treasury strategy.
The investment follows NewGen's initial US$2 million investment announced in May 2026 and a subsequent US$4 million investment announced on June 4, 2026. To facilitate this acquisition, NewGenIVF Group Limited issued 3,666,667 new shares. The completion of the Pre-A round provides K25.ai with strategic backing as it moves toward product launch. Concurrently, K25.ai has commenced its Series A fundraising, which is intended to support commercialization, applicable regulatory licensing, and expansion across selected Asian markets.
K25.ai operates as an AI-native livestreaming and watch-to-predict information market platform purpose-built for the Asia-Pacific region. The company is developing a new category of interactive information markets, combining creator-led livestreaming, AI-assisted market creation and resolution, and real-time community participation.
Investment Details
The following table outlines the sequence of investments made by NewGenIVF Group Limited in K25.ai:
| Date | Investment Amount | Round |
|---|---|---|
| May 2026 | US$2 million | Initial Investment |
| June 4, 2026 | US$4 million | Subsequent Investment |
| June 18, 2026 | US$4 million | Pre-A Completion |
Strategic Objectives
With the Pre-A round closed, K25.ai is positioned to accelerate its product launch and regional expansion. The Series A funds will be utilized to drive commercialization efforts and secure necessary regulatory licenses. NewGen's increased equity position and exclusive regional rights align with its strategy to integrate advanced AI-driven platforms within its diversified growth portfolio. NewGen believes it is now well-positioned to meet Nasdaq’s proposed minimum Market Value of Listed Securities (MVLS) threshold of US$5 million.
What is the projected timeline for K25.ai's product launch following the completion of the Pre-A round?
How will K25.ai navigate the specific regulatory landscapes required for commercialization across selected Asian markets?
What are the key performance indicators NewGen will use to evaluate the success of its exclusive Asia-Pacific agency rights?

























